Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.24 -0.59 (-7.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Depreciation and Depletion (2023 - 2025)

Updated

Eupraxia Pharmaceuticals' Depreciation and Depletion came in at $72,806 for the quarter ended Dec 31, 2025, up 33.6% from $54,512 a year earlier and up 15.6% from the prior quarter.

Analysis

Eupraxia Pharmaceuticals (EPRX) Depreciation and Depletion (2023 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Eupraxia Pharmaceuticals' Depreciation and Depletion was $237,717, up 38.4% from the prior year.

  • Depreciation and Depletion has increased in each of the last three years, with a three-year compound annual growth rate of 17.1% (years ended Dec 2022 to Dec 2025).
  • Going back by year, Depreciation and Depletion was $171,719 in the year ended Dec 31, 2024 (+10.4%), $155,527 in the year ended Dec 31, 2023 (+5.2%) and $147,894 in the year ended Dec 31, 2022.
  • The figure for the quarter ended Dec 31, 2025 represents the highest quarterly Depreciation and Depletion in data going back to the quarter ended Mar 31, 2023.
  • Year-over-year, Depreciation and Depletion has increased for five consecutive quarters, with growth averaging 24.5% over the last eight quarters.
  • The fastest year-over-year change in Depreciation and Depletion over five years came in the quarter ended Sep 30, 2025 (growth of 66.8%), and the weakest in the quarter ended Sep 30, 2024 (a decline of 2.5%).
  • Business Quant data shows EPRX's Depreciation and Depletion at $62,993 (quarter ended Sep 30, 2025), $55,431 (quarter ended Jun 30, 2025) and $46,487 (quarter ended Mar 31, 2025) in the three quarters before the quarter ended Dec 31, 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Eupraxia Pharmaceuticals 312.86 Mn 311.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 72,806.00
Sep 30, 2025 62,993.00
Jun 30, 2025 55,431.00
Mar 31, 2025 46,487.00
Dec 31, 2024 54,512.00
Sep 30, 2024 37,759.00
Jun 30, 2024 42,030.00
Mar 31, 2024 37,418.00
Dec 31, 2023 41,233.00
Sep 30, 2023 38,716.00
Jun 30, 2023 38,122.00
Mar 31, 2023 37,456.00
API Access

Eupraxia Pharmaceuticals Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=EPRX&period=max&api_key=YOUR_API_KEY